MICROANEURYSM FORMATION RATE AS A PREDICTIVE MARKER FOR PROGRESSION TO CLINICALLY SIGNIFICANT MACULAR EDEMA IN NONPROLIFERATIVE DIABETIC RETINOPATHY

被引:53
|
作者
Haritoglou, Christos [1 ]
Kernt, Marcus [1 ]
Neubauer, Aljoscha [1 ]
Gerss, Joachim [2 ]
Oliveira, Carlos Manta [3 ]
Kampik, Anselm [1 ]
Ulbig, Michael [1 ]
机构
[1] Univ Munich, Dept Ophthalmol, D-80336 Munich, Germany
[2] Univ Munster, Inst Biostat & Clin Res, D-48149 Munster, Germany
[3] Crit Hlth SA, Coimbra, Portugal
关键词
diabetic macular edema; progression; microaneurysm turnover; TURNOVER;
D O I
10.1097/IAE.0b013e318295f6de
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To evaluate the predictive value of microaneurysm (MA) formation rate concerning the development of clinically significant macular edema (CSME) in patients with mild-to-moderate nonproliferative diabetic retinopathy as evaluated by an automated analysis of central field fundus 30 degrees photographs. Methods: Two hundred and eighty-seven eyes were included in the study. Photographs obtained at Day 0, at 6, and 12 months were analyzed using the RetmarkerDR software (Critical Health SA) in a masked manner, and the MA formation rate was documented. A threshold of a calculated MA formation rate of 2 or more was chosen to consider a patient "positive." The ability to predict CSME development was then calculated for a period of up to 5 years. HbA1c values, blood pressure, or duration of diabetes were also evaluated. Results: The study population consisted of 89 male and 59 female patients with a mean age of 57.6 years, a mean HbA1c of 7.8, and a mean duration of diabetes of 12.3 years. Forty-seven of 287 eyes (16.4%) developed CSME during follow-up. An increased MA formation rate of > 2 MA was clearly associated with development of CSME. Using the automated analysis and a threshold of 2 or more new MA, the authors were able to identify 70.2% of the eyes that developed CSME during follow-up ("true positive") and using a threshold of up to 2 new MA, 71.7% of the patients that did not develop CSME ("true negative"). No significant differences concerning baseline and 1-year HbA1c levels within patient eyes that developed CSME compared with patient eyes below or over the calculated threshold of 2 MA (P = 0.554 and P = 0.890, respectively) were seen. The positive and negative predictive value was calculated to be 33% versus 92.5%, sensitivity was 70%, and specificity was 72%. Conclusion: Using the RetmarkerDR software, the authors were able to identify patients with higher risk to develop CSME during follow-up using a threshold of 2 or more MA formation rate. Together with the high negative predictive value, the automated analysis may help to determine the individual risk of a patient to develop sight-threatening complications related to diabetic retinopathy and schedule individual screening intervals.
引用
收藏
页码:157 / 164
页数:8
相关论文
共 50 条
  • [41] Retreatment of Clinically Significant Diabetic Macular Edema: Effect on contrast sensitivity
    RoldanPallares, M
    ElBromboly, TH
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1996, 37 (03) : 4388 - 4388
  • [42] Effect of posture on the diurnal variation in clinically significant diabetic macular edema
    Polito, Antonio
    Polini, Giovanni
    Chiodini, Raffaella Gortana
    Isola, Miriam
    Soldano, Franca
    Bandello, Francesco
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2007, 48 (07) : 3318 - 3323
  • [43] Effect of topical nepafenac in prevention of macular edema after cataract surgery in patients with nonproliferative diabetic retinopathy
    Sarfraz, Muhammad Haroon
    Ul Haq, Rana Intisar
    Mehboob, Mohammad Asim
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2017, 33 (01) : 210 - 214
  • [44] Design, baseline patient characteristics and high prevalence of clinically significant macular edema (CSME) in patients with moderately severe to very severe nonproliferative diabetic retinopathy (NPDR) in the protein kinase c diabetic retinopathy study (PKC-DRS)
    Aiello, LP
    Davis, MD
    Sheetz, MJ
    Arora, V
    Milton, RC
    DIABETES, 2002, 51 : A209 - A209
  • [45] Efficacy of intravitreal conbercept combined with panretinal photocoagulation for severe nonproliferative diabetic retinopathy without macular edema
    Zhao, Ning
    Guan, Jian
    Cai, Na
    Liu, Ning-Ning
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2022, 15 (04) : 615 - 619
  • [46] Efficacy of intravitreal conbercept combined with panretinal photocoagulation for severe nonproliferative diabetic retinopathy without macular edema
    Ning Zhao
    Jian Guan
    Na Cai
    Ning-Ning Liu
    International Journal of Ophthalmology, 2022, (04) : 615 - 619
  • [47] Correlation between microaneurysm closure rate and reduction in macular thickness following laser photocoagulation of diabetic macular edema
    N Sachdev
    V Gupta
    V Abhiramamurthy
    R Singh
    A Gupta
    Eye, 2008, 22 : 975 - 977
  • [48] Optical coherence tomography titrated photocoagulation in diabetic clinically significant macular edema
    Das, T
    Simanjuntak, G
    Sumasri, K
    MACULA: DIAGNOSIS, TREATMENT AND FUTURE TRENDS, 2004, : 185 - 194
  • [49] Diurnal variation in clinically significant diabetic macular edema measured by the stratus OCT
    Polito, A
    Del Borrello, M
    Polini, G
    Furlan, F
    Isola, M
    Bandello, F
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2006, 26 (01): : 14 - 20
  • [50] VISUAL-FIELD IN TREATMENT CONTROL OF CLINICALLY SIGNIFICANT DIABETIC MACULAR EDEMA
    ROLDANPALLARES, M
    ELBROMBOLY, TH
    VILARMASEDA, NF
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1995, 36 (04) : S482 - S482